Clinical Trials · NCT06388642
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Clinuvel Europe Limited
- Enrollment
- 28
- Start date
- Mar 2024
- Locations
- 2 sites, Belgium, Netherlands
- Primary endpoint
- Cmax (Maximum Plasma Concentration)